NCT01911754View on ClinicalTrials.gov

Japanese Pediatric H5N1 Vaccine Study

PHASE3CompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

April 30, 2014

Conditions

Influenza

Interventions

BIOLOGICAL

H5N1 (Pre-)Pandemic Influenza Vaccine (Whole Virion, Vero Cell-Derived, Inactivated)

Trial Locations (2)

890-0063

Minami Clinic, Kagoshima

890-0082

Shibahara Tahara Hospital, Kagoshima

Sponsors

Collaborators (1)

Baxter Innovations GmbH

All Listed Sponsors

collaborator

Baxter Innovations GmbH

INDUSTRY

lead

Alachua Government Services, Inc.

INDUSTRY

NCT01911754 - Japanese Pediatric H5N1 Vaccine Study | Biotech Hunter | Biotech Hunter